Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Rapid Molecular Test Detects Macrolide Resistance

By LabMedica International staff writers
Posted on 13 Mar 2019
Emerging antimicrobial resistance is a significant threat to human health. More...
However, methods for rapidly diagnosing antimicrobial resistance generally require multi-day culture-based assays. Current methods of assessing antimicrobial resistance are extremely slow, requiring days to weeks of culture time, and are also costly in terms of laboratory materials and technician effort.

The rise of antibiotic-resistant bacteria is a growing problem in the USA and the world. In the USA annually, more than two million people get infections that are resistant to antibiotics and at least 23,000 people die as a result. A new, highly sensitive rapid genetic test has been developed that can determine whether bacteria carries a gene that causes resistance to two common antibiotics used to treat strep throat and other respiratory illnesses.

Microbiologists at the American University (Washington, DC, USA) developed and tested a novel Recombinase Polymerase Amplification (RPA) assay for the detection of the Macrolide Efflux A (mef(A)) gene, an efflux pump rendering host bacteria resistant to 14- and 15-membered macrolide antibiotics (including erythromycin A and azithromycin). This gene can be found within Streptococcus pyogenes, the largest member of the Lancefield group A streptococci.

Primers and probe for the mef(A) RPA assay were designed following the instructions provided by TwistDx (Cambridge, UK). The team used purified DNA, a panel of bacteria cultures, and broth dilution antimicrobial resistance testing, and demonstrated extreme sensitivity and specificity of the RPA assay, and they confirm that positive results correctly predict antimicrobial resistance. The RPA assay uncovered an unexpected occurrence of the mef(A) gene within commensal Streptococcus salivarius strain, and subsequent laboratory testing confirmed that this strain has genuine antimicrobial resistance.

The team tested eight bacterial strains in total: S. pyogenes (2 strains), S. agalactiae, S. salivarius, S. pneumoniae (3 strains), and E. faecium. RPA confirmed the presence of mef(A) within all known positive strains and none of the known negatives. Megan M. Nelson, MSc, the first author of the study, said, “Our rapid genetic test can help doctors better assign medication on site, and improve point-of-care diagnostics, potentially leading to better outcomes without having prescribed a patient a useless antibiotic. There's a lot of trial and error with antibiotic use, so this is trying to take out some of the error.” The study was published on February 12, 2019, in the journal BMC Infectious Diseases.

Related Links:
American University
TwistDx


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Specimen Radiography System
TrueView 200 Pro
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.